Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Monday 21 October, 2019

CompuGroup Medical SE

Release of a capital market information

DGAP Post-admission Duties announcement: CompuGroup Medical SE / Share Buyback
CompuGroup Medical SE: Release of a capital market information

21.10.2019 / 13:04
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 5th Interim Announcement

CompuGroup Medical SE / Share Buyback

 

Koblenz, October 21, 2019

CompuGroup Medical SE: Disclosure pursuant to Art. 5 Para. 1 lit. b) and Para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 Para. 2 and Para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 - 5th Interim Announcement

In the period from October 14, 2019, up to and including October 18, 2019, CompuGroup Medical SE has bought back a total of 48,869 shares of CompuGroup Medical SE within the framework of the share buyback program. In the announcement of September 17, 2019, pursuant to Art. 2 para. 1 of the Commission Delegated Regulation (EU) 2016/1052 supplementing Regulation (EU) No 596/2014 (MAR) it was communicated that the repurchase of treasury shares would commence on September 18, 2019.

The overall volume of the shares bought back daily in the period from October 14, 2019, up to and including October 18, 2019, and the daily volume-weighted average stock market prices of the shares are as follows:

Date Overall volume of shares bought back (number) Volume-weighted average stock market price
(EUR, excluding ancillary costs of purchase, rounded to four places according to commercial practice)
October 14, 2019 6,667 54.6407
October 15, 2019 11,625 55.8820
October 16, 2019 9,983 56.8939
October 17, 2019 9,450 56.8294
October 18, 2019 11,144 56.6623
     
In total: 48,869 56.2805
 

The total number of shares which have been bought back so far by CompuGroup Medical SE since September 18, 2019, up to and including October 18, 2019, within the framework of the share buyback program thus amounts to 309,558 no-par value shares.

Further information pursuant to Art. 5 para. 1 lit. b) and para. 3 of the Regulation (EU) No 596/2014 (MAR) in conjunction with Art. 2 para. 2 and para. 3 of the Commission Delegated Regulation (EU) No 2016/1052 is available online under https://www.cgm.com/sbb.

The purchase of the shares of CompuGroup Medical SE was carried out by a bank assigned by CompuGroup Medical SE and exclusively via the Frankfurt Stock Exchange (Xetra trading).

The Management Board

CompuGroup Medical SE
Investor Relations
Maria Trost 21
56070 Koblenz, Germany
T: 49 (0) 261 8000-6200
F: 49 (0) 261 8000-3200



21.10.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: CompuGroup Medical SE
Maria Trost 21
56070 Koblenz
Germany
Internet: www.cgm.com

 
End of News DGAP News Service

893363  21.10.2019 

fncls.ssp?fn=show_t_gif&application_id=893363&application_name=news&site_id=financialexpress

a d v e r t i s e m e n t